The reason why patients with severe COVID-19 develop lymphopenia requires further investigation, especially since studies have shown that lymphocytes do not express a high level of angiotensin-converting enzyme 2 (ACE2), the cell entry receptor for the coronavirus [27,28]. Here, ACE2 is linked to COVID-19.